Scientists have pinpointed nearly 300 "hotspots" in the human genome that may increase the risk of bipolar disorder. In the ...

Agreement drives continued patient access to four important therapies in Japan and KoreaStrengthens Essential Pharma and Clinigen’s combined ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

A hotel guest killed a receptionist during a psychotic episode because he felt "judged" when she smiled at him, an inquest ...